Hypertension, Post-stroke
Conditions
Interventions
Participants will be treated with 20mg olmesartan tablet once in the morning for 24 weeks.
Sponsors
University of Toyama
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Hypertensive patients with post stroke state (except cardiogenic embolism and subarachnoid hemorrhage) Outpatients 20 years old or older at the time of the informed consent
Exclusion criteria
Exclusion criteria: Myocardial infarction, cerebral infarction, cerebral hemorrhage, subarachnoid hemorrhage, unknown type of stroke within previous 6 months (TIA can be registerd) Grade III hypertension (systolic BP>=180mmHg or diastolic BP>=110mmHg) Percutaneous or surgical coronary intervention (PCI, CABG etc.), severe heart failure within 6 months Percutaneous or surgical coronary intervention planned Persistent or permanent atrial fibrillation History of congenital heart disease, rheumatic heart disease, moderate or severe valvular heart disease Unstable angina, severe arrhythmia Pregnant, possible to pregnancy Not appropriate to long term observation Difficult to obtain consent because of minors or dementia etc.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Evaluation at 12 week and 24 week after 1) Blood pressure self-measured at home (home BP) in the early morning and evening, Morning/Evening ratio 2) Blood pressure at hospital (hospital BP) 3) The achievement rate of target blood pressures (at hospital and home) | — |
Countries
Japan
Contacts
Public ContactNaoki Akioka
University of Toyama Department of Neurosurgery
Outcome results
None listed